Skip to main content

Table 1 Demographics and lesion characteristics of patients undergoing percutaneous transthoracic needle biopsy for persistent pulmonary consolidation

From: Clinical role, safety and diagnostic accuracy of percutaneous transthoracic needle biopsy in the evaluation of pulmonary consolidation

Characteristics No (%)
Age, yr. (mean ± SD) 67 ± 10
Sex
 Male 17 (57)
 Female 13 (43)
Smoking history
 Non-smoker 8 (27)
 Current smoker 4 (13)
 Former smoker 18 (60)
Bronchoscopy prior to PTNB
 No 23 (77)
 Yes 7 (23)
Underlying disease
 None 6 (20)
 Lung cancer 15 (50)
 Other malignancy 4 (13)
  Leukemia 1 (3)
  Lymphoma 1 (3)
  Pancreatic cancer 1 (3)
  Breast cancer 1 (3)
 Immunocompromised 1 (3)
 Pulmonary disease 4 (13)
Indication for biopsy
 R/O Infection 9 (30)
 R/O Cancer 9 (30)
 Molecular testing in known lung cancer 12 (40)
Treatment before biopsy
 None 23 (77)
 Antibiotic 5 (17)
 Steroid 1 (3)
 Antibiotic and Steroid 1 (3)
 Chemotherapy and/or targeted therapy 15 (50)
Emphysema
 Absent 20 (67)
 Present 10 (33)
Lobar involvement of consolidation
  < 1/2 Lobe 10 (33)
  > 1/2 Lobe 5 (17)
  > Lobe 15 (50)
Distribution
 Single lung 18 (60)
 Bilateral 12 (40)
Location of biopsied consolidation
 Right upper lobe 6 (20)
 Right middle lobe 2 (7)
 Right lower lobe 7 (23)
 Left upper lobe 10 (33)
 Left lower lobe 5 (17)
Ground glass component
 Absent 10 (33)
 Present 20 (67)
Cavitation
 Absent 26 (87)
 Present 4 (13)
Hilar adenopathy
 Absent 21 (70)
 Present 9 (30)
Mediastinal adenopathy
 Absent 22 (73)
 Present 8 (24)
Pleural effusion
 Absent 17 (57)
 Present 13 (43)